{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T15:10:18Z","timestamp":1789139418584,"version":"build-2803163510"},"reference-count":11,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,8,2]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>Macrolides are an essential component of non-tuberculous mycobacterium management and being labelled with an allergy can result in these medications being avoided despite them being the preferred treatment. There are few existing case reports describing macrolide de-labelling. These relied on time-consuming tests which delayed the onset of treatment. In contrast, this report describes a case of successful macrolide allergy de-labelling within an ambulatory setting following appropriate risk assessment involving the immunology team. This allowed commencement of appropriate macrolide therapy in a timely fashion.<\/jats:p>","DOI":"10.1136\/bcr-2026-275061","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T11:35:22Z","timestamp":1786534522000},"page":"e275061","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Macrolide allergy de-labelling in non-tuberculous mycobacterium treatment"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-9672-830X","authenticated-orcid":false,"given":"Thomas","family":"Heather","sequence":"first","affiliation":[{"name":"Harrogate and District NHS Foundation Trust, Harrogate, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karadana","family":"Dharmasena","sequence":"additional","affiliation":[{"name":"Harrogate and District NHS Foundation Trust, Harrogate, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wakefield","sequence":"additional","affiliation":[{"name":"Harrogate and District NHS Foundation Trust, Harrogate, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,11]]},"reference":[{"key":"2026091107251126000_19.8.e275061.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00535-2020"},{"key":"2026091107251126000_19.8.e275061.2","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-213929"},{"key":"2026091107251126000_19.8.e275061.3","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2016-209729"},{"key":"2026091107251126000_19.8.e275061.4","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2018-316397"},{"key":"2026091107251126000_19.8.e275061.5","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.18203\/2394-6040.ijcmph20222971","article-title":"Classification and management of hypersensitivity reactions","volume":"9","author":"Baik","year":"2022","journal-title":"Int J Community Med Public Health"},{"key":"2026091107251126000_19.8.e275061.6","unstructured":"Patel PH , Hashmi MF . Macrolides. In: StatPearls. Treasure Island (FL): StatPearls Publishing, 2025. Available: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551495\/"},{"key":"2026091107251126000_19.8.e275061.7","doi-asserted-by":"publisher","DOI":"10.2174\/138161208786369812"},{"key":"2026091107251126000_19.8.e275061.8","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/pharmacy7030135","article-title":"Macrolide Allergic Reactions","volume":"7","author":"Shaeer","year":"2019","journal-title":"Pharmacy"},{"key":"2026091107251126000_19.8.e275061.9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jaip.2013.01.013","article-title":"Successful clarithromycin desensitization in a macrolide-sensitive pediatric patient","volume":"1","author":"Petitto","year":"2013","journal-title":"J Allergy Clin Immunol Pract"},{"key":"2026091107251126000_19.8.e275061.10","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.anai.2010.08.018","article-title":"Successful Clarithromycin Desensitization in a Multiple Macrolide\u2013Allergic Patient","volume":"105","author":"Swamy","year":"2010","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"2026091107251126000_19.8.e275061.11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2125.2008.03192.x","article-title":"Report of oral clarithromycin desensitization","volume":"66","author":"Holmes","year":"2008","journal-title":"Brit J Clinical Pharma"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2026-275061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T14:25:21Z","timestamp":1789136721000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2026-275061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":11,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,11]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bcr-2026-275061"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2026-275061","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}